Skip to content

Clinical trials

Terminated Carcinoma, Non-Small-Cell Lung trials in Denmark

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Carcinoma, Non-Small-Cell Lung Status: Terminated Country / region: Denmark Clear all

15 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20071
20102
20111
20121
20131
20172
20181
20192
20201
20222

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Terminated15

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Rigshospitalet, Denmark3
Novartis Pharmaceuticals2
Amgen1
Black Diamond Therapeutics, Inc.1
Daiichi Sankyo1
Eli Lilly and Company1
Genmab1
Herlev Hospital1
Navire Pharma Inc., a BridgeBio company1
Pfizer1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Carcinoma, Non-Small-Cell Lung15
Neoplasm Metastasis4
Lung Neoplasms3
Breast Neoplasms2
Neoplasms2
Triple Negative Breast Neoplasms2
Urinary Bladder Neoplasms2
Biliary Tract Neoplasms1
Carcinoma1
Carcinoma, Ovarian Epithelial1

Trials

Showing 1 to 15 of 15. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.